Association of glycolysis-related protein expression with prognosis in Canine Pulmonary Adenocarcinoma Authors: Ami AOYAMA, Taiki KATO, Masanao ICHIMATA, Kosuke KOBAYASHI, Masashi SAKURAI, Yumiko KAGAWA, Hiroto TOYODA, Ryuzo KATAYAMA, Kei HARADA, Eri FUKAZAWA, Fukiko MATSUYAMA, Tetsuya KOBAYASHI, Takuya MIZUNO, Masaya IGASE Published: 2026 ABSTRACT Canine pulmonary adenocarcinoma (CPAC) is a rare, aggressive tumor with no established prognostic molecular biomarkers. The expression of monocarboxylate transporter 4 (MCT4) and glucose transporter 1 (GLUT1), key glycolysis-related proteins, is induced by hypoxia and is generally associated with poor prognosis in human pulmonary adenocarcinoma; however, their clinical significance in dogs remains unclear. This study investigated the expression of MCT4 and GLUT1 in 61 CPAC cases. Immunohistochemistry revealed significantly higher MCT4 and GLUT1 expression in tumors compared with normal lung tissues. High expression of both proteins was associated with lymph node metastasis. Kaplan–Meier analysis showed that high MCT4 expression was associated with prolonged overall survival, while GLUT1 showed no prognostic impact. However, MCT4 was not retained as an independent prognostic factor in multivariable Cox proportional hazards analysis. These results suggest that MCT4 and GLUT1 are upregulated in CPAC and may have distinct biological and clinical significance compared with human pulmonary adenocarcinoma. INTRODUCTION Tumor metabolism depends on glycolysis, with glucose uptake mediated by glucose transporter 1 (GLUT1) and adenosine triphosphate generated through the glycolytic pathway [17]. Lactate, a glycolysis byproduct, is exported via monocarboxylate transporter 4 (MCT4), acidifying the tumor microenvironment [3]. This metabolic reprogramming is regulated by hypoxia-inducible factors, particularly hypoxia-inducible factor 1α (HIF1α), which is activated under hypoxia and overexpressed in various malignancies. HIF1α promotes angiogenesis, invasion, metastasis, augmented glucose metabolism, and adaptation to acidic conditions, with high expression associated with increased metastatic potential and poor prognosis [23]. Glycolysis-related transporters MCT4 and GLUT1 are upregulated in several human cancers, including lung [19, 20, 22], breast [2], and hepatocellular carcinoma [1], and their elevated expressions are correlated with tumor progression and poor prognosis. Primary lung cancer is one of the most common and deadly cancers in humans, with adenocarcinoma as the predominant subtype, and advances in molecular targeted therapies have deepened the understanding of its pathogenesis. In dogs, primary lung cancer is rare, but adenocarcinoma is the most frequent form and shares histological features with human lung adenocarcinoma [15]. Canine pulmonary adenocarcinoma (CPAC) primarily affects older dogs, often remains subclinical in the early stage, and typically progresses to chronic respiratory signs like cough. Surgery is the primary treatment, with adjuvant chemotherapy or radiotherapy used selectively [12, 13, 15]. Previous studies in small-breed dogs with pulmonary adenocarcinoma identified tumor size, surgical margin status, and Human Epidermal Growth Factor Receptor 2 (HER2) mutation as predictors of tumor progression and survival. [5, 6] Although many dogs achieve long-term survival after surgery, some have poor outcomes, underscoring the need for reliable prognostic biomarkers. In human lung adenocarcinoma, high MCT4 and GLUT1 expression is associated with increased malignancy, metastasis, and worse prognosis [19, 20]. However, their expression and prognostic relevance have not yet been studied in CPAC. Although immunohistochemical analyses of clinical specimens can clarify the prognostic relevance of glycolysis-related markers, they provide limited insight into their functional roles within tumor cells. Therefore, we first performed in vitro experiments using CPAC cell lines cultured under normoxic and hypoxic conditions to characterize hypoxia-associated regulation and the biological significance of key glycolysis-related transporters, including MCT4 and GLUT1. We then evaluated MCT4 and GLUT1 expression by immunohistochemistry in clinical CPAC specimens and examined their associations with clinicopathologic variables and outcome, to determine their potential utility as prognostic biomarkers and therapeutic targets. MATERIALS AND METHODS Cell culture The CPAC-derived cell line CPACd-p [9] was cultured in Dulbecco’s modified Eagle medium supplemented with 10% fetal bovine serum (FBS), 100 U/mL penicillin–streptomycin, and 55 µM 2-mercaptoethanol, and maintained at 37°C in 5% CO2. Hypoxic conditions (1% O2, 5% CO2, 37°C) and normoxic conditions (21% O2, 5% CO2, 37°C) were applied a multi-gas incubator (SA-30D, Astec, Fukuoka, Japan), as previously described [7]. Protein extraction and Western blotting The in vitro hypoxia experiments in this study were designed to evaluate the time-dependent induction of hypoxia-responsive proteins, including MCT4, GLUT1, and HIF1α. CPACd-p cells were seeded in 9.2-cm2 petri dishes at a density of 5 × 105 cells and incubated overnight under normoxia. After replacing the culture supernatant, cells were cultured for 0, 3, 6, and 24 hr under normoxic or hypoxic conditions. Cells were then harvested and lysed with NP40-based buffer (1% NP40, 10 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, protease inhibitor cocktails (Nacalai Tesque, Kyoto, Japan), 1 mM Na3VO4, and 50 mM NaF), to extract total protein, which was separated by 10% acrylamide gel electrophoresis (SuperSep Ace, FujiFilm, Tokyo, Japan). Proteins were transferred to a PVDF membrane (Merck, Darmstadt, Germany) and blocked for 1 hr at room temperature (RT) in Tris-buffered saline with 0.05% Tween 20 and 5% skimmed milk. The membrane was incubated overnight at 4°C with primary antibodies diluted in TBS-T (Tris-buffered saline with 0.05% Tween-20) containing 5% bovine serum albumin (BSA): mouse anti-human HIF1α (H1α67, Novus Biologicals, Centennial, CO, USA) [7], rabbit anti-human MCT4 (Novus Biologicals) [7], rabbit anti-human GLUT1 (Abcam, Cambridge, UK) [16].The membrane was then incubated for 1 hr at RT with horseradish peroxidase (HRP)–conjugated secondary antibodies: anti-rabbit IgG (Jackson ImmunoResearch, West Baltimore Pike, West Grove, PA, USA) or HRP-conjugated anti-mouse IgG (BioLegend, San Diego, CA, USA). Mouse anti-β-actin monoclonal antibody served as a loading control. Finally, specific proteins were visualized using ECL reagent (PerkinElmer, Waltham, MA, USA) and subsequently detected with AMERSHAM Image Quant 800 (Global Life Sciences Technologies Japan, Tokyo, Japan). Specimens Normal lung tissues (n=6) were obtained from our laboratory’s archival collection of healthy canine samples or from the Laboratory of Veterinary Pathology at Yamaguchi University. CPAC tumor tissues (n=72) were retrieved from our institutional archive and included dogs from previous retrospective cohort studies [5, 6]. Cases comprised dogs seen at the Japan Small Animal Cancer Center between May 2005 and November 2021 with histologically confirmed lung adenocarcinoma. Eleven dogs lacking tumor tissue or censored from progression-free survival (PFS) analysis were excluded. As no new animal experiments were conducted, an ethics committee approval was not required. Immunohistochemistry Paraffin-embedded tissue sections (4 µm thick) were placed on MAS-coated glass slides (Matsunami glass kogyo, Osaka, Japan). After deparaffinization and alcohol rehydration, antigens were retrieved by autoclaving in Dako Target Retrieval Solution pH9 (Agilent Technologies Japan, Ltd., Tokyo, Japan) for 20 min at 121°C. Endogenous peroxidase activity was blocked with 3% H2O2 in methanol for 30 min at RT, followed by rinsing in phosphate-buffered saline (PBS). Subsequently, the sections were blocked with 5% BSA and 5% skimmed milk in PBS for 30 min at RT. The sections were then incubated overnight at 4°C with rabbit anti-MCT4 polyclonal antibody (Novus Biologicals), rabbit anti-human GLUT1 polyclonal antibody (Abcam), or rabbit IgG isotype control (DA1E, Cell Signaling Technology, Danvers, MA, USA) diluted in 2% BSA in PBS. The sections were treated with Histofine Simple Stain MAX PO (Nichirei Corp., Tokyo, Japan) for 30 min at RT as the secondary antibody. After the PBS washes, color was developed using diaminobenzidine (Nacalai Tesque) to produce a brown precipitate, followed by nuclear counterstaining with Mayer’s hematoxylin. The sections were mounted using an aqueous mounting medium. Five random fields per slide were selected, and cases were considered positive if membranous staining of MCT4 or GLUT1 was detected. Quantitative analysis of MCT4- and GLUT1-positive areas was performed using ImageJ software, as previously reported [8]. The scale unit was converted from pixels to micrometers (µm), RGB channels were separated, and blue channel intensity was subtracted from the red channel intensity. A threshold was set to define the positive staining area for quantification. A fixed threshold was set for MCT4 and GLUT1 in each case. The positive area was measured in five randomly selected fields, and the mean value was calculated to represent the expression score for each tissue sample. MCT4 and GLUT1 expression scores were analyzed as continuous variables and dichotomized at the median for association analyses (low,